H Michael Shepard

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Bao Ying Chen, Jessica R Salas, Alyssa O Trias, Arely Perez Rodriguez, Jonathan E Tsang, Miriam Guemes, Thuc M Le, Zoran Galic, H Michael Shepard, Lawrence Steinman, David A Nathanson, Johannes Czernin, Owen N Witte, Caius G Radu, Kenneth A Schultz, Peter M Clark
Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis. Immunology (2022)
Lin Wang, Luz M Londono, Jessica Cowell, Ozge Saatci, Mertkaya Aras, Pelin G Ersan, Sara Serra, Hong Pei, Renee Clift, Qiping Zhao, Kim B Phan, Lei Huang, Michael J LaBarre, Xiaoming Li, H Michael Shepard, Silvia Deaglio, Joel Linden, Christopher D Thanos, Özgür Sahin, Caglar Cekic
Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors. Cancer research 81 (12) (2021)

H Michael Shepard.css-eqlu8i{font-size:small;padding-left:4px;}